Ghrelin plasma levels in patients with idiopathic short stature

Hormone Research in Paediatrics

Volumn 75, Issue 2, 2011, Pages 94-100

  Iñiguez, Germán ^a   Román, Rossana ^a   Youlton, Ronald ^b   Cassorla, Fernando ^a   Mericq, Verónica ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b CLÍNICA LAS CONDES   (Chile)

Author keywords

Ghrelin; Growth hormone secretagogue receptor; Idiopathic short stature

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; SOMATOMEDIN C;

ARTICLE; BODY HEIGHT; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HORMONE BLOOD LEVEL; HUMAN; IDIOPATHIC SHORT STATURE; MALE; PREPUBERTY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SCHOOL CHILD; SHORT STATURE;

BODY HEIGHT; CHILD; DWARFISM; FEMALE; GHRELIN; HUMANS; MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, GHRELIN;

EID: 79951810017     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000317429     Document Type: Article

References (34)

1. Schiller S, Spranger S, Schechinger B, Fukami M, Merker S, Drop SL, Troger J, Knoblauch H, Kunze J, Seidel J, Rappold GA: Phenotypic variation and genetic heterogeneity in Leri-Weill syndrome. Eur J Hum Genet 2000; 8: 54-62. (Pubitemid 30113796)
2. Ross JL, Scott C Jr, Marttila P, Kowal K, Nass A, Papenhausen P, Abboudi J, Osterman L, Kushner H, Carter P, Ezaki M, Elder F, Wei F, Chen H, Zinn AR: Phenotypes associated with SHOX deficiency. J Clin Endocrinol Metab 2001; 86: 5674-5680. (Pubitemid 33152606)
3. Marchini A, Häcker B, Marttila T, Hesse V, Emons J, Weiss B, Karperien M, Rappold G: BNP is a transcriptional target of the short stature homeobox gene SHOX. Hum Mol Genet 2007; 16: 3081-3087. (Pubitemid 350131326)
4. Bowers CY, Momany F, Reynolds GA, Chang D, Hong A, Chang K: Structure-activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro. Endocrinology 1980; 106: 663-667. (Pubitemid 10135092)
5. Mericq V, Cassorla F, Garcia H, Avila A, Bowers CY, Merriam GR: Growth hormone (GH) responses to GH-releasing peptide and to GH-releasing hormone in GH-deficient children. J Clin Endocrinol Metab 1995; 80: 1681-1684.
6. Kojima M, Hosoda H, Matsuo H, Kangawa K: Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001; 12: 118-122. (Pubitemid 33714199)
7. Papotti M, Ghè C, Cassoni P, Catapano F, Deghenghi R, Ghigo E, Muccioli G: Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab 2000; 85: 3803-3807.
8. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJ, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, DeMartino JA, Gupta SK, Schaeffer JM, Smith RG, Van der Ploeg LH, et al: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996; 273: 974-977. (Pubitemid 26275178)
9. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growthhormone- releasing acylated peptide from stomach. Nature 1999; 402: 656-660. (Pubitemid 129516334)
10. Feighner SD, Howard AD, Prendergast K, Palyha OC, Hreniuk DL, Nargund R, Underwood D, Tata JR, Dean DC, Tan CP, McKee KK, Woods JW, Patchett AA, Smith RG, Van der Ploeg LH: Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues. Mol Endocrinol 1998; 12: 137-145. (Pubitemid 28124786)
11. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M: Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255-4261.
12. Pantel J, Legendre M, Cabrol S, Hilal L, Hajaji Y, Morisset S, Nivot S, Vie-Luton MP, Grouselle D, de Kerdanet M, Kadiri A, Epelbaum J, Le Bouc Y, Amselem S: Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 2006; 116: 760-768. (Pubitemid 43326885)
13. Pantel J, Legendre M, Nivot S, Morisset S, Vie-Luton MP, le Bouc Y, Epelbaum J, Amselem S: Recessive isolated growth hormone deficiency and mutations in the ghrelin receptor. J Clin Endocrinol Metab 2009; 94: 4334-4341.
14. Tschop M, Smiley DL, Heiman ML: Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-913.
15. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura Sl: A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198. (Pubitemid 32144284)
16. Shintani M, Ogawa Y, Ebihara K, Aizawa- Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K: Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001; 50: 227-232. (Pubitemid 32127276)
17. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML: Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-709. (Pubitemid 32242624)
18. Mericq V, Cassorla F, Bowers CY, Avila A, Gonen B, Merriam GRJ: Changes in appetite and body weight in response to long-term oral administration of the ghrelin agonist GHRP-2 in growth hormone deficient children. J Pediatr Endocrinol Metab 2003; 16: 981-985. (Pubitemid 37259185)
19. Kuczmarski RJ, Ogden, CL, Grummer- Strawn LM, et al: CDC Growth Charts: United States. Advance Data from Vital and Health Statistics, No. 314. Hyattsville, National Center for Health Statistics, 2000.
20. Youlton R, Valenzuela C: Growth patterns in height and weight in children aged 0 to 17 years and cranial circumference in children aged 0 to 2 years from medium-high and high socioeconomic status in Santiago. Comparison with growth in children from medium-low and low status in the Northern area of Santiago. Rev Chil Pediatr 1990(spec No):1-22.
21. Beas F, Barrera R, Corvalan L, Cortinez A, Eggers M, Henriquez C: Anthropometric parameters in male Chilean adolescents of median- high socioeconomic level. Rev Chil Pediatr 1986; 57: 485-490.
22. Cifuentes L, Valenzuela CY, Cruz-Coke R, Armanet L, Lyng C, Harb Z: Genetic characterization of the hospital population of Santiago, Chile. Rev Med Chile 1988; 116: 28-33.
23. Iñiguez G, Ong K, Bazaes R, Avila A, Salazar T, Dunger D, Mericq V: Longitudinal changes in insulin-like growth factor-I, insulin sensitivity, and secretion from birth to age three years in small-for-gestational-age children. J Clin Endocrinol Metab 2006; 91: 4645-4649. (Pubitemid 44833451)
24. Iñiguez G, Salazar T, Roman R, Avila A, Gunn RD, Cassorla F: Effects of the IGF-I/ IGFBP-3 complex on GH and ghrelin nocturnal concentrations in low birth weight children. Clin Endocrinol (Oxf) 2006; 65: 687-692. (Pubitemid 44583833)
25. Camurdan MO, Bideci A, Demirel F, Cinaz P: Serum ghrelin, IGF-I and IGFBP-3 levels in children with normal variant short stature. Endocr J 2006; 53: 479-484. (Pubitemid 44351498)
26. Wang HJ, Geller F, Dempfle A, Schäuble N, Friedel S, Lichtner P, Fontenla-Horro F, Wudy S, Hagemann S, Gortner L, Huse K, Remschmidt H, Bettecken T, Meitinger T, Schäfer H, Hebebrand J, Hinney A: Ghrelin receptor gene: identification of several sequence variants in extremely obese children and adolescents, healthy normal-weight and underweight students, and children with short normal stature. J Clin Endocrinol Metab 2004; 89: 157-162. (Pubitemid 38183875)
27. Garcia EA, Heude B, Petry CJ, Gueorguiev M, Hassan-Smith ZK, Spanou A, Ring SM, Dunger DB, Wareham N, Sandhu MS, Ong KK, Korbonits M: Ghrelin receptor gene polymorphisms and body size in children and adults. J Clin Endocrinol Metab 2008; 93: 4158-4161.
28. Hosoda H, Kojima M, Kangawa K: Ghrelin and the regulation of food intake and energy balance. Mol Interv 2002; 2: 494-503.
29. Broglio F, Gottero C, Prodam F, Gauna C, Muccioli G, Papotti M, Abribat T, Van Der Lely AJ, Ghigo E: Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab 2004; 89: 3062-3065. (Pubitemid 38766409)
30. Toshinai K, Yamaguchi H, Sun Y, Smith RG, Yamanaka A, Sakurai T, Date Y, Mondal MS, Shimbara T, Kawagoe T, Murakami N, Miyazato M, Kangawa K, Nakazato M: Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology 2006; 147: 2306-2314.
31. Asakawa A, Inui A, Fujimiya M, Sakamaki R, Shinfuku N, Ueta Y, Meguid MM, Kasuga M: Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005; 54: 18-24. (Pubitemid 40007213)
32. Kirchner H, Gutierrez JA, Solenberg PJ, Pfluger PT, Czyzyk TA, Willency JA, Schürmann A, Joost HG, Jandacek RJ, Hale JE, Heiman ML, Tschöp MH: GOAT links dietary lipids with the endocrine control of energy balance. Nat Med 2009; 15: 741-745.
33. Thompson NM, Gill DA, Davies R, Loveridge N, Houston PA, Robinson IC, Wells T: Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor. Endocrinology 2004; 145: 234-242. (Pubitemid 38202164)
34. Kim HJ, Lee S, Kim TW, Kim HH, Jeon TY, Yoon YS, Oh SW, Kwak H, Lee JG: Effects of exercise-induced weight loss on acylated and unacylated ghrelin in overweight children. Clin Endocrinol (Oxf) 2008; 68: 416-422. (Pubitemid 351257861)